Xenon Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is …
Biotechnology
CA, Burnaby [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of XENE's Analysis
CIK: 1582313 CUSIP: 98420N105 ISIN: CA98420N1050 LEI: - UEI: -
Secondary Listings
XENE has no secondary listings inside our databases.